Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Go back to Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights| (NASDAQ: CADL) | Delayed: 11.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.21 | 52 Week High | $ | |||
| Open | $11.21 | 52 Week Low | $ | |||
| Day High | $11.21 | P/E | N/A | |||
| Day Low | $11.21 | EPS | $ | |||
| Volume | 1,033 | |||||

